Traws Pharma (TRAW)
NASDAQ:TRAW
Holding TRAW?
Track your performance easily

Traws Pharma (TRAW) Stock Investors

1,795 Followers
Based on 756,513 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TRAW
On average, investors allocate 0.00% of their portfolios to TRAW
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 756,513 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TRAW

1.4%
Last 7
Days
9.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TRAW, out of 756,513 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TRAW Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,457 investors who made their portfolios public
The table shows changes in TRAW in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TRAW Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Plug Power
5.10%
-1.47%
-2.82%
1.72B
Industrials
DraftKings
5.56%
+0.02%
+1.73%
33.21B
Consumer Cyclical
Blink Charging Co
5.31%
-1.26%
-3.47%
186.12M
Industrials
Nio
9.93%
-1.08%
-1.08%
11.00B
Consumer Cyclical
Riot Platforms
4.74%
-0.68%
-1.88%
2.19B
Financial
Lucid Group
5.95%
-0.69%
-0.52%
9.14B
Consumer Cyclical
Marathon Digital Holdings
5.33%
-1.09%
-1.71%
4.75B
Financial
GE Aerospace
5.33%
+0.15%
+3.53%
193.31B
Industrials
XPeng, Inc. ADR
5.47%
-1.28%
-2.63%
8.27B
Consumer Cyclical
Block
4.18%
-0.68%
-2.44%
39.40B
Technology
Based on the activity of 756,513 active portfolios
Open your Smart Portfolio

TRAW Investor Analysis

TRAW investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
10.9%
of TRAW holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
TRAW investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
67.2%
of TRAW holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
TRAW investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
21.9%
of TRAW holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of TRAW stock investors
See who invests in TRAW according to age group and performance.

FAQ

How many retail Investors hold TRAW?
<0.1% of TipRanks' retail investors hold TRAW in their portfolios.
    What is TRAW Investor Sentiment?
    TRAW’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of TRAW in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of TRAW in the last 7 days.
        What percentage of retail investors changed their holding of TRAW in the last 30 days?
        ▲ 9.3% of TipRanks' retail investors changed their holding of TRAW in the last 30 days.
          What is the average age of retail investors who hold TRAW?
          The average age of TRAW Holders is between 35–55.
            What other stocks have TRAW investors also bought?
            TRAW Investors also bought PLUG, DKNG, BLNK, NIO, RIOT, LCID, MARA, GE, XPEV, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BSXBoston Scientific
              CPRXCatalyst Pharma
              DXCMDexcom
              EXASExact Sciences
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis